Labwire, Inc.
LBWR · OTC
12/31/2022 | 12/31/2008 | 12/31/2007 | |
|---|---|---|---|
| Revenue | $0 | $4 | $5 |
| % Growth | -100% | -11.6% | – |
| Cost of Goods Sold | $0 | $2 | $3 |
| Gross Profit | $0 | $2 | $2 |
| % Margin | – | 44.6% | 33% |
| R&D Expenses | $0 | $0 | $0 |
| G&A Expenses | $0 | $2 | $1 |
| SG&A Expenses | $0 | $2 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 |
| Operating Expenses | $0 | $2 | $1 |
| Operating Income | -$0 | -$0 | $0 |
| % Margin | – | -1.5% | 5.3% |
| Other Income/Exp. Net | $0 | -$0 | -$0 |
| Pre-Tax Income | -$0 | -$0 | $0 |
| Tax Expense | $0 | $0 | $0 |
| Net Income | -$0 | -$0 | $0 |
| % Margin | – | -4.8% | 3.6% |
| EPS | 0 | -0.001 | 0.001 |
| % Growth | 100% | -216.7% | – |
| EPS Diluted | 0 | -0.001 | 0.001 |
| Weighted Avg Shares Out | 167 | 142 | 140 |
| Weighted Avg Shares Out Dil | 167 | 142 | 140 |
| Supplemental Information | – | – | – |
| Interest Income | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 |
| EBITDA | $0 | -$0 | $0 |
| % Margin | – | -0.1% | 5.8% |